novo nordisk semaglutide mash Wegovy Is Now the Second FDA-Approved Treatment for Fibrosis India approves Novo Nordisk's obesity

Clinical trials show that weight regain after discontinuation is common, with most people regaining a significant portion of lost weight within a year of stopping

End-of-week patterns and injection timing Many GLP-1 medication users report a distinct weekly pattern to their sulfur burps

Possible causes include a defect in the protective lining of the bladder wall, increased release of histamines, an increased number of nerve cells, and an autoimmune process (when antibodies are made that act against a part of the body) to name a few

Does drinking more water fix GLP-1 dry mouth

Check the Red List

The NIDA has identified these approaches as effective for treating addiction